Cargando…
Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala
BACKGROUND: A low cost and accurate method for detecting high-risk (HR) human papillomavirus (HPV) is important to permit HPV testing for cervical cancer prevention. We used a commercially available HPV method (H13, Hybribio) which was documented to function accurately in a reduced volume of cervica...
Autores principales: | Lou, Hong, Gharzouzi, Eduardo, Guerra, Sarita Polo, Domgue, Joël Fokom, Sawitzke, Julie, Villagran, Guillermo, Garland, Lisa, Boland, Joseph F., Wagner, Sarah, Rosas, Héctor, Troxler, Jami, McMillen, Heidi, Kessing, Bailey, Alvirez, Enrique, Castillo, Miriam, Morales, Hesler, Argueta, Victor, Rosingh, Andert, van Aerde-van Nunen, Femke J. H. B., Lopez, Griselda, Pinedo, Herbert M., Schiffman, Mark, Dean, Michael, Orozco, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952444/ https://www.ncbi.nlm.nih.gov/pubmed/29764400 http://dx.doi.org/10.1186/s12885-018-4438-y |
Ejemplares similares
-
Correction to: Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in Guatemala
por: Lou, Hong, et al.
Publicado: (2020) -
Treatment Compliance as a Major Barrier to Optimal Cervical Cancer Treatment in Guatemala
por: Zamorano, Abigail S., et al.
Publicado: (2019) -
Is It Relevant to Keep Advocating Visual Inspection of the Cervix With Acetic Acid for Primary Cervical Cancer Screening in Limited-Resource Settings?
por: Fokom Domgue, Joel, et al.
Publicado: (2017) -
Assessment of Trends in Cigarette Smoking Cessation After Cancer Diagnosis Among US Adults, 2000 to 2017
por: Talluri, Rajesh, et al.
Publicado: (2020) -
Reasons for not receiving the HPV vaccine among eligible adults: Lack of knowledge and of provider recommendations contribute more than safety and insurance concerns
por: Fokom Domgue, Joël, et al.
Publicado: (2020)